Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway.

Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA.

Neuroscience. 2009 Mar 31;159(3):993-1002. doi: 10.1016/j.neuroscience.2009.01.017. Epub 2009 Jan 19.

2.

Resveratrol and ischemic preconditioning in the brain.

Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ, Perez-Pinzon MA.

Curr Med Chem. 2008;15(15):1545-51. Review.

PMID:
18537630
3.

New role of silent information regulator 1 in cerebral ischemia.

Yang Y, Duan W, Li Y, Yan J, Yi W, Liang Z, Wang N, Yi D, Jin Z.

Neurobiol Aging. 2013 Dec;34(12):2879-88. doi: 10.1016/j.neurobiolaging.2013.06.008. Epub 2013 Jul 12. Review.

PMID:
23855981
4.

Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning.

Morris KC, Lin HW, Thompson JW, Perez-Pinzon MA.

J Cereb Blood Flow Metab. 2011 Apr;31(4):1003-19. doi: 10.1038/jcbfm.2010.229. Epub 2011 Jan 12. Review.

5.

Sirtuin activators and inhibitors.

Villalba JM, Alcaín FJ.

Biofactors. 2012 Sep-Oct;38(5):349-59. doi: 10.1002/biof.1032. Epub 2012 Jun 25. Review.

6.

Neuroprotective role of mitochondrial uncoupling protein 2 in cerebral stroke.

Mehta SL, Li PA.

J Cereb Blood Flow Metab. 2009 Jun;29(6):1069-78. doi: 10.1038/jcbfm.2009.4. Epub 2009 Feb 25. Review.

PMID:
19240738
7.

Ischemic preconditioning and clinical scenarios.

Narayanan SV, Dave KR, Perez-Pinzon MA.

Curr Opin Neurol. 2013 Feb;26(1):1-7. doi: 10.1097/WCO.0b013e32835bf200. Review.

8.

Biochemical effects of SIRT1 activators.

Baur JA.

Biochim Biophys Acta. 2010 Aug;1804(8):1626-34. doi: 10.1016/j.bbapap.2009.10.025. Epub 2009 Nov 6. Review.

9.

Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?

de Ligt M, Timmers S, Schrauwen P.

Biochim Biophys Acta. 2015 Jun;1852(6):1137-44. doi: 10.1016/j.bbadis.2014.11.012. Epub 2014 Nov 18. Review.

10.

Signal transducers and activators of transcription: STATs-mediated mitochondrial neuroprotection.

Lin HW, Thompson JW, Morris KC, Perez-Pinzon MA.

Antioxid Redox Signal. 2011 May 15;14(10):1853-61. doi: 10.1089/ars.2010.3467. Epub 2011 Jan 5. Review.

11.

Renal protective effects of resveratrol.

Kitada M, Koya D.

Oxid Med Cell Longev. 2013;2013:568093. doi: 10.1155/2013/568093. Epub 2013 Nov 28. Review.

12.

A critical review of mechanisms regulating remote preconditioning-induced brain protection.

Meller R, Simon RP.

J Appl Physiol (1985). 2015 Nov 15;119(10):1135-42. doi: 10.1152/japplphysiol.00169.2015. Epub 2015 May 7. Review.

13.

Protective effects and mechanisms of sirtuins in the nervous system.

Zhang F, Wang S, Gan L, Vosler PS, Gao Y, Zigmond MJ, Chen J.

Prog Neurobiol. 2011 Nov;95(3):373-95. doi: 10.1016/j.pneurobio.2011.09.001. Epub 2011 Sep 10. Review.

14.

Mitochondrial mechanisms in cerebral vascular control: shared signaling pathways with preconditioning.

Busija DW, Katakam PV.

J Vasc Res. 2014;51(3):175-89. doi: 10.1159/000360765. Epub 2014 May 22. Review.

15.

Cytoprotective Effect of the UCP2-SIRT3 Signaling Pathway by Decreasing Mitochondrial Oxidative Stress on Cerebral Ischemia-Reperfusion Injury.

Su J, Liu J, Yan XY, Zhang Y, Zhang JJ, Zhang LC, Sun LK.

Int J Mol Sci. 2017 Jul 24;18(7). pii: E1599. doi: 10.3390/ijms18071599. Review.

16.

Role of sirtuins in ischemia-reperfusion injury.

Pantazi E, Zaouali MA, Bejaoui M, Folch-Puy E, Ben Abdennebi H, Roselló-Catafau J.

World J Gastroenterol. 2013;19(43):7594-602. doi: 10.3748/wjg.v19.i43.7594. Review.

17.

The molecular targets of resveratrol.

Kulkarni SS, Cantó C.

Biochim Biophys Acta. 2015 Jun;1852(6):1114-23. doi: 10.1016/j.bbadis.2014.10.005. Epub 2014 Oct 12. Review.

18.

Small-molecule allosteric activators of sirtuins.

Sinclair DA, Guarente L.

Annu Rev Pharmacol Toxicol. 2014;54:363-80. doi: 10.1146/annurev-pharmtox-010611-134657. Epub 2013 Oct 16. Review.

19.

Resveratrol neuroprotection in stroke and traumatic CNS injury.

Lopez MS, Dempsey RJ, Vemuganti R.

Neurochem Int. 2015 Oct;89:75-82. doi: 10.1016/j.neuint.2015.08.009. Epub 2015 Aug 12. Review.

20.

Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds.

Bonkowski MS, Sinclair DA.

Nat Rev Mol Cell Biol. 2016 Nov;17(11):679-690. doi: 10.1038/nrm.2016.93. Epub 2016 Aug 24. Review.

PMID:
27552971

Supplemental Content

Support Center